Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP687806.RA-dpzsvvFHCKEnKGaa7F0c3slV328NE3z9S7JkJtF4dw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP687806.RA-dpzsvvFHCKEnKGaa7F0c3slV328NE3z9S7JkJtF4dw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP687806.RA-dpzsvvFHCKEnKGaa7F0c3slV328NE3z9S7JkJtF4dw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP687806.RA-dpzsvvFHCKEnKGaa7F0c3slV328NE3z9S7JkJtF4dw130_provenance.
- NP687806.RA-dpzsvvFHCKEnKGaa7F0c3slV328NE3z9S7JkJtF4dw130_assertion description "[A dual inhibitor of PI3K and mTOR, PI-103, was more effective than rapamycin at suppressing proliferation of mouse pre-B-ALL and human CD19+CD34+)Ph+ ALL leukemia cells treated with the ABL kinase inhibitor imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687806.RA-dpzsvvFHCKEnKGaa7F0c3slV328NE3z9S7JkJtF4dw130_provenance.
- NP687806.RA-dpzsvvFHCKEnKGaa7F0c3slV328NE3z9S7JkJtF4dw130_assertion evidence source_evidence_literature NP687806.RA-dpzsvvFHCKEnKGaa7F0c3slV328NE3z9S7JkJtF4dw130_provenance.
- NP687806.RA-dpzsvvFHCKEnKGaa7F0c3slV328NE3z9S7JkJtF4dw130_assertion SIO_000772 18704194 NP687806.RA-dpzsvvFHCKEnKGaa7F0c3slV328NE3z9S7JkJtF4dw130_provenance.
- NP687806.RA-dpzsvvFHCKEnKGaa7F0c3slV328NE3z9S7JkJtF4dw130_assertion wasDerivedFrom befree-2016 NP687806.RA-dpzsvvFHCKEnKGaa7F0c3slV328NE3z9S7JkJtF4dw130_provenance.
- NP687806.RA-dpzsvvFHCKEnKGaa7F0c3slV328NE3z9S7JkJtF4dw130_assertion wasGeneratedBy ECO_0000203 NP687806.RA-dpzsvvFHCKEnKGaa7F0c3slV328NE3z9S7JkJtF4dw130_provenance.
- befree-2016 importedOn "2016-02-19" NP687806.RA-dpzsvvFHCKEnKGaa7F0c3slV328NE3z9S7JkJtF4dw130_provenance.